Prophylaxis for Venous Thromboembolic Events in Elective Total Hip and Total Knee Arthroplasty

被引:12
|
作者
Karasavvidis, Theofilos [1 ]
Bouris, Vasileios [2 ]
Xiang, William [3 ]
Tzavellas, Georgios [4 ]
Charisis, Nektarios [5 ]
Palaiodimos, Leonidas [6 ]
Kigka, Vassiliki [7 ]
Bourantas, Christos, V [8 ,9 ]
Gkiatas, Ioannis [3 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Thessaloniki, Greece
[2] Gen Hosp Athens G Genimatas, Dept Vasc Surg, Athens, Greece
[3] Univ Ioannina, Sch Med, Dept Orthopaed Surg, Ioannina, Greece
[4] Ball Mem Hosp, Dept Vasc Surg, Muncie, IN 47303 USA
[5] Stony Brook Univ Hosp, Dept Surg, Stony Brook, NY USA
[6] Albert Einstein Coll Med, Dept Med, Bronx, NY USA
[7] Univ Ioannina, Sch Med, Ioannina, Greece
[8] UCL, Inst Cardiovasc Sci, London, England
[9] Barts Hlth NHS Trust, Dept Cardiol, London, England
关键词
Pharmaceutical prophylaxis; venous thromboembolism; total hip and total knee arthroplasty; vitamin K antagonists; oral anticoagulants; hematoma; MOLECULAR-WEIGHT HEPARIN; TOTAL JOINT ARTHROPLASTY; THROMBOPROPHYLAXIS; ENOXAPARIN; ASPIRIN; REPLACEMENT; METAANALYSIS; RIVAROXABAN; PREVENTION; WARFARIN;
D O I
10.2174/1381612828666220418090928
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Venous thromboembolism (VTE) is a serious complication after major orthopaedic operations. such as a total hip (THA) and knee (TKA) arthroplasty. Therefore, perioperative VTE prophylaxis is recommended: a multitude of modem options are available, including both pharmacologic (aspirin, unfractionated and low-molecular-weight heparin, vitamin K antagonists, and novel oral anticoagulants) and/or mechanical interventions (early mobilization, graduated compression stockings, intermittent pneumatic compression devices, and venous foot pumps). However, because of the abundance of these possibilities, it is crucial to understand the benefits and drawbacks of each VTE prophylaxis option to ensure that the optimal treatment plan is developed for each patient. The American College of Chest Physicians (AACP) and the American Academy of Orthopaedic Surgeons (AAOS) have both published individual guidelines on VTE prophylaxis regimens, alongside numerous studies evaluating the efficacy and outcomes of the different prophylaxis modalities. The purpose of this review is to provide a summary of the evidence on VTE prophylaxis after elective total hip and knee arthroplasty based on current guidelines and highlight the major concerns and potential complications.
引用
收藏
页码:771 / 777
页数:7
相关论文
共 50 条
  • [31] Venous Thromboembolism Prophylaxis after Total Knee Arthroplasty
    Box, Hayden N.
    Shahrestani, Sean
    Huo, Michael H.
    JOURNAL OF KNEE SURGERY, 2018, 31 (07) : 605 - 609
  • [32] Surveillance for venous thromboembolic disease after total knee arthroplasty
    Berry, DJ
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2001, (392) : 257 - 266
  • [33] The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty
    Tyagi, Vineet
    Tomaszewski, Paul
    Lukasiewicz, Adam
    Theriault, Shahana
    Pelker, Richard
    ORTHOPEDICS, 2018, 41 (01) : E98 - E103
  • [34] Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Hip and Knee Arthroplasty
    Mont, Michael A.
    Jacobs, Joshua J.
    Boggio, Lisa N.
    Bozic, Kevin John
    Della Valle, Craig J.
    Goodman, Stuart Barry
    Lewis, Courtland G.
    Yates, Adolph J., Jr.
    Watters, William Charles, III
    Turkelson, Charles M.
    Wies, Janet L.
    Donnelly, Patrick
    Patel, Nilay
    Sluka, Patrick
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2011, 19 (12) : 768 - 776
  • [35] Prevalence of Venous Thromboembolic Events Is Low in Asians After Total Knee Arthroplasty Without Chemoprophylaxis
    Bin Abd Razak, Hamid Rahmatullah
    Abd Razak, Noorul Faeyza Binte
    Tan, Hwee-Chye Andrew
    JOURNAL OF ARTHROPLASTY, 2017, 32 (03): : 974 - 979
  • [36] Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty
    Singh, Jasvinder A.
    Jensen, Matthew R.
    Harmsen, William Scott
    Gabriel, Sherine E.
    Lewallen, David G.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (12) : 2082 - 2088
  • [37] Quality indicators in primary elective total hip and knee arthroplasty
    Scott Kim
    Justin Cottrell
    James Waddell
    Eric Bohm
    Sam Adie
    Sarah Ward
    Jennifer Leighton
    Earl Bogoch
    David Backstein
    Michael Dunbar
    Bassam Masri
    Michael Zywiel
    Eric Monteiro
    Jesse Isaac Wolfstadt
    International Orthopaedics, 2023, 47 : 647 - 658
  • [38] Quality indicators in primary elective total hip and knee arthroplasty
    Kim, Scott
    Cottrell, Justin
    Waddell, James
    Bohm, Eric
    Adie, Sam
    Ward, Sarah
    Leighton, Jennifer
    Bogoch, Earl
    Backstein, David
    Dunbar, Michael
    Masri, Bassam
    Zywiel, Michael
    Monteiro, Eric
    Wolfstadt, Jesse Isaac
    INTERNATIONAL ORTHOPAEDICS, 2023, 47 (03) : 647 - 658
  • [39] Use of Aspirin versus Rivaroxaban in postoperative thromboembolic prophylaxis after primary total hip and knee arthroplasty
    Donkerwolke, Simon
    Fischer, Jean-Francois
    Deslarzes, Philip
    Abou-Khalil, Sami
    Royon, Thibaut
    SWISS MEDICAL WEEKLY, 2021, 151 : 63S - 63S
  • [40] Novel venous thromboembolic disease (VTED) prophylaxis for total knee arthroplasty-aspirin and fish oil
    Bonutti, Peter M.
    Sodhi, Nipun
    Patel, Yatindra H.
    Sultan, Assem A.
    Khlopas, Anton
    Chughtai, Morad
    Kolisek, Frank R.
    Williams, Nick
    Mont, Michael A.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5